vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FINANCIAL INSTITUTIONS INC (FISI). Click either name above to swap in a different company.
FINANCIAL INSTITUTIONS INC is the larger business by last-quarter revenue ($62.7M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). FINANCIAL INSTITUTIONS INC runs the higher net margin — 33.5% vs -19.9%, a 53.4% gap on every dollar of revenue. Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -2.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
The Mizuho Financial Group, Inc. , known from 2000 to 2003 as Mizuho Holdings and abbreviated as MHFG or simply Mizuho, is a Japanese banking holding company headquartered in the Ōtemachi district of Chiyoda, Tokyo, Japan. The group was formed in 2000–2002 by merger of Dai-Ichi Kangyo Bank, Fuji Bank, and Industrial Bank of Japan. The name mizuho (瑞穂) literally means "abundant rice" in Japanese and "harvest" in the figurative sense.
ABCL vs FISI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $62.7M |
| Net Profit | $-8.9M | $21.0M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 33.5% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | 24.3% |
| EPS (diluted) | $-0.03 | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $62.7M | ||
| Q4 25 | $44.9M | $64.1M | ||
| Q3 25 | $9.0M | $63.8M | ||
| Q2 25 | $17.1M | $59.7M | ||
| Q1 25 | $4.2M | $57.2M | ||
| Q4 24 | $5.0M | $41.6M | ||
| Q3 24 | $6.5M | $50.1M | ||
| Q2 24 | $7.3M | $65.2M |
| Q1 26 | — | $21.0M | ||
| Q4 25 | $-8.9M | $20.0M | ||
| Q3 25 | $-57.1M | $20.5M | ||
| Q2 25 | $-34.7M | $17.5M | ||
| Q1 25 | $-45.6M | $16.9M | ||
| Q4 24 | — | $-82.8M | ||
| Q3 24 | $-51.1M | $13.5M | ||
| Q2 24 | $-36.9M | $25.6M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 37.4% | ||
| Q3 25 | -851.8% | 39.5% | ||
| Q2 25 | -290.2% | 36.0% | ||
| Q1 25 | -1479.6% | 36.0% | ||
| Q4 24 | — | -276.9% | ||
| Q3 24 | -1439.4% | 29.0% | ||
| Q2 24 | -1276.2% | 46.2% |
| Q1 26 | — | 33.5% | ||
| Q4 25 | -19.9% | 38.3% | ||
| Q3 25 | -637.8% | 32.1% | ||
| Q2 25 | -203.3% | 29.3% | ||
| Q1 25 | -1077.2% | 29.5% | ||
| Q4 24 | — | -198.9% | ||
| Q3 24 | -785.4% | 26.9% | ||
| Q2 24 | -504.3% | 39.3% |
| Q1 26 | — | $1.04 | ||
| Q4 25 | $-0.03 | $0.96 | ||
| Q3 25 | $-0.19 | $0.99 | ||
| Q2 25 | $-0.12 | $0.85 | ||
| Q1 25 | $-0.15 | $0.81 | ||
| Q4 24 | — | $-5.32 | ||
| Q3 24 | $-0.17 | $0.84 | ||
| Q2 24 | $-0.13 | $1.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $85.5M |
| Total DebtLower is stronger | — | $114.0M |
| Stockholders' EquityBook value | $966.9M | — |
| Total Assets | $1.4B | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $85.5M | ||
| Q4 25 | $128.5M | $108.8M | ||
| Q3 25 | $83.2M | $185.9M | ||
| Q2 25 | $92.4M | $93.0M | ||
| Q1 25 | $159.3M | $167.4M | ||
| Q4 24 | $156.3M | $87.3M | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | $114.0M | ||
| Q4 25 | — | $193.7M | ||
| Q3 25 | — | $115.0M | ||
| Q2 25 | — | $115.0M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $124.8M | ||
| Q3 24 | — | $124.8M | ||
| Q2 24 | — | $124.7M |
| Q1 26 | — | — | ||
| Q4 25 | $966.9M | $628.9M | ||
| Q3 25 | $964.0M | $621.7M | ||
| Q2 25 | $1.0B | $601.7M | ||
| Q1 25 | $1.0B | $589.9M | ||
| Q4 24 | $1.1B | $569.0M | ||
| Q3 24 | $1.1B | $500.3M | ||
| Q2 24 | $1.1B | $467.7M |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $1.4B | $6.3B | ||
| Q3 25 | $1.4B | $6.3B | ||
| Q2 25 | $1.4B | $6.1B | ||
| Q1 25 | $1.3B | $6.3B | ||
| Q4 24 | $1.4B | $6.1B | ||
| Q3 24 | $1.4B | $6.2B | ||
| Q2 24 | $1.4B | $6.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $18.8M | ||
| Q3 25 | $-52.6M | $-6.9M | ||
| Q2 25 | $-32.4M | $-5.7M | ||
| Q1 25 | $-11.6M | $10.0M | ||
| Q4 24 | $-108.6M | $77.1M | ||
| Q3 24 | $-28.9M | $2.1M | ||
| Q2 24 | $-30.0M | $35.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $13.3M | ||
| Q3 25 | $-61.5M | $-7.9M | ||
| Q2 25 | $-45.8M | $-7.3M | ||
| Q1 25 | $-22.2M | $9.2M | ||
| Q4 24 | $-187.0M | $72.2M | ||
| Q3 24 | $-47.4M | $-299.0K | ||
| Q2 24 | $-50.1M | $34.7M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 20.7% | ||
| Q3 25 | -687.0% | -12.4% | ||
| Q2 25 | -267.9% | -12.3% | ||
| Q1 25 | -524.0% | 16.1% | ||
| Q4 24 | -3702.8% | 173.3% | ||
| Q3 24 | -728.4% | -0.6% | ||
| Q2 24 | -683.8% | 53.3% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 8.7% | ||
| Q3 25 | 99.7% | 1.6% | ||
| Q2 25 | 78.2% | 2.7% | ||
| Q1 25 | 251.1% | 1.4% | ||
| Q4 24 | 1552.7% | 11.9% | ||
| Q3 24 | 284.6% | 4.9% | ||
| Q2 24 | 274.6% | 1.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | -0.33× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
FISI
| Net Interest Income | $52.0M | 83% |
| Noninterest Income | $10.7M | 17% |
